19 related articles for article (PubMed ID: 17565850)
1. Dendritic cells are dysfunctional in patients with operable breast cancer.
Satthaporn S; Robins A; Vassanasiri W; El-Sheemy M; Jibril JA; Clark D; Valerio D; Eremin O
Cancer Immunol Immunother; 2004 Jun; 53(6):510-8. PubMed ID: 14740176
[TBL] [Abstract][Full Text] [Related]
2. [CpG-ODN instillation boosts ICAM-1 expression in an orthotopic murine UCC model: immunohistochemical evaluation of the local response to immunostimulatory DNA].
Klebe M; Olbert PJ; Hofmann R; Barth PJ; Hegele A
Aktuelle Urol; 2024 Apr; 55(2):154-160. PubMed ID: 33853160
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory effects of Diospyros peregrina fruit preparation (DFP) in non-small cell lung cancer (NSCLC) by utilizing dendritic cell-mediated antigen presentation and T helper (TH) cell differentiation.
Sriraman N; Sarkar A; Naskar S; Mahajan N; Mukherjee O; Pradeep R; George M; Sarkar K
Med Oncol; 2024 Apr; 41(5):107. PubMed ID: 38580762
[TBL] [Abstract][Full Text] [Related]
4. A phase 2, single-arm study of an autologous dendritic cell treatment against mucin 1 in patients with advanced epithelial ovarian cancer.
Mitchell PL; Quinn MA; Grant PT; Allen DG; Jobling TW; White SC; Zhao A; Karanikas V; Vaughan H; Pietersz G; McKenzie IF; Gargosky SE; Loveland BE
J Immunother Cancer; 2014; 2():16. PubMed ID: 24995129
[TBL] [Abstract][Full Text] [Related]
5. DC-derived CXCL10 promotes CTL activation to suppress ovarian cancer.
Dong M; Lu L; Xu H; Ruan Z
Transl Res; 2024 May; 272():126-139. PubMed ID: 38823437
[TBL] [Abstract][Full Text] [Related]
6. [Immunosuppressive action of dendritic cells sensitized by oligodeoxynucleotides and CA125 on human OVCAR3 ovarian carcinoma xenografts in nude mice].
Ye M; Li N; Huang X; Wang D; Shang J
Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(15):1193-5. PubMed ID: 24924723
[TBL] [Abstract][Full Text] [Related]
7. [Inducing hepatocellular carcinoma-specific cytotoxic T lymphocyte response using formed by fusion of FastDCs and allogeneic human hepatocellular carcinoma cells].
Guan X; Leng XS; Peng JR; Wei YH; Wang H; Yuan L
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3332-6. PubMed ID: 16409838
[TBL] [Abstract][Full Text] [Related]
8. APC stimulated by CpG oligodeoxynucleotide enhance activation of MHC class I-restricted T cells.
Warren TL; Bhatia SK; Acosta AM; Dahle CE; Ratliff TL; Krieg AM; Weiner GJ
J Immunol; 2000 Dec; 165(11):6244-51. PubMed ID: 11086059
[TBL] [Abstract][Full Text] [Related]
9. [Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].
Ren T; Cai YY; Liang YJ; Jin ML; Guo ZL; Tao MF; He X
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1168-72. PubMed ID: 18844109
[TBL] [Abstract][Full Text] [Related]
10. [Induction of active antitumor immune response by myeloma idiotype protein-pulsed dendritic cells].
Yin XR; Zhang M; Luo YY; Lin X; He PC; Chen LM; Cai RB; Guo GL
Ai Zheng; 2005 Jun; 24(6):657-62. PubMed ID: 15946473
[TBL] [Abstract][Full Text] [Related]
11. [Cytotoxicity of dendritic cells pulsed by CpG ODN on ovarian carcinoma cells: in vitro experiment with ovarian carcinoma cells].
Ye MZ; Li HL; Han LY
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(11):778-82. PubMed ID: 17565850
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
